Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference
19 nov. 2024 16h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced...
Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics
14 nov. 2024 16h05 HE
|
Codexis, Inc.
—Becomes first company to showcase four routes of synthesis for approved siRNA therapeutic asset— —Joint poster with Bachem demonstrates superiority of Company’s double-stranded RNA ligases compared...
Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors
12 nov. 2024 16h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced...
Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics
11 nov. 2024 16h05 HE
|
Codexis, Inc.
—Spotlight Presentation to showcase four routes of synthesis of an approved siRNA therapeutic asset— —Joint poster presentation with Bachem to compare Codexis double-stranded RNA ligase to wild-type...
Codexis Announces New Employment Inducement Grants
08 nov. 2024 16h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced...
Codexis to Participate in Upcoming Healthcare Conferences
04 nov. 2024 16h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced...
Codexis Reports Third Quarter 2024 Financial Results
31 oct. 2024 16h05 HE
|
Codexis, Inc.
Quarter Highlights Include Key Additions to Management Team and Extension of Cash Runway into 2027 with $31M Raise via ATM Facility Company Reiterates Full-year Financial Guidance; On Track to...
Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting
24 oct. 2024 16h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced...
Codexis Announces New Employment Inducement Grants
14 oct. 2024 07h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced...
Codexis to Report Third Quarter 2024 Financial Results on October 31
10 oct. 2024 16h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced...